Vaccines
-
September 18, 2014
Initiative seeks to develop therapies to combat Ebola
Vanderbilt University researchers have partnered with Mapp Biopharmaceutical Inc. to develop new human antibody therapies for people exposed to the deadly Ebola and Marburg viruses. -
April 7, 2014
Vanderbilt Vaccine Center joins global task force to address urgent viral threat
-
March 6, 2014
Multi-center effort targets lethal Ebola, Marburg viruses
Vanderbilt University researchers are collaborating in a multi-center, federally-funded project to develop ways to treat and prevent the highly lethal Ebola and Marburg virus infections. -
August 22, 2013
Vaccine researchers ready as new flu strain evolves
A worrisome new avian influenza virus, called H7N9, emerged this spring in Eastern China. -
May 30, 2013
Study lays groundwork for rational T cell vaccine design
Vanderbilt University investigators have developed a new strategy for identifying the “bits” of a pathogen that spark a protective immune response. -
May 16, 2013
Grant targets new therapies for Ebola, Marburg viruses
Vanderbilt’s James Crowe Jr., M.D., and a collaborator in Texas have been awarded a $4.4 million grant from the U.S. Department of Defense to study new ways to treat and prevent Ebola and Marburg viruses. -
July 19, 2012
Long antibodies better against HIV
Understanding how antibodies with long “loops” form may be important for HIV vaccine development.